Inventor · Guilford, CT, US

Eric Mull

25Patents
7h-index
57Co-inventors
68Inventor score

Filing activity: Sep 23, 2002 → Jul 9, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9308236B2 Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Emerging Cross-Sectional Technologies 24 Active
US9732119B2 Immunomodulators Emerging Cross-Sectional Technologies 14 Active
US9879046B2 Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Emerging Cross-Sectional Technologies 13 Active
US8445490B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 11 Active
US9850283B2 Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Physics 9 Active
US9944678B2 Immunomodulators Emerging Cross-Sectional Technologies 8 Active
US10143746B2 Immunomodulators Human Necessities 8 Active
US10538555B2 Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Emerging Cross-Sectional Technologies 7 Active
US10144706B2 Compounds useful as immunomodulators Chemistry; Metallurgy 7 Active
US8765944B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 7 Active
US10450347B2 Immunomodulators Emerging Cross-Sectional Technologies 6 Active
US8586584B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 6 Active
US10358463B2 Immunomodulators Emerging Cross-Sectional Technologies 6 Active
US8741884B2 Compounds for the treatment of hepatitis C Human Necessities 4 Active
US6900205B2 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders Chemistry; Metallurgy 4 Expired
US7109196B2 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders Chemistry; Metallurgy 4 Expired
US8957203B2 Hepatitis C virus inhibitors Human Necessities 2 Active
US10745382B2 Compounds useful as immunomodulators Emerging Cross-Sectional Technologies 2 Active
US11066445B2 Immunomodulators acting as antagonists of PD-1 Human Necessities 2 Active
US10745384B2 Indazole derivatives as αv integrin antagonists Chemistry; Metallurgy 1 Active
US11028071B2 Indazole derivatives as alpha v integrin antagonists Chemistry; Metallurgy 0 Active
US9527885B2 Hepatitis C virus inhibitors Human Necessities 0 Active
US9598433B2 Hepatitis C virus inhibitors Chemistry; Metallurgy 0 Active
US9624245B2 Macrocyclic compounds as HCV entry inhibitors Chemistry; Metallurgy 0 Active
US9499550B2 Hepatitis C virus inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.